Klinički bolnički centar Sestre milosrdnice je jedan od dva zagrebačka klinička bolnička centra. Nastavna je baza za Medicinski i Stomatološki fakultet te nastavna baza za Pravni, Filozofski, Prirodoslovno-matematički, Edukacijsko-rehabilitacijski fakultet, Farmaceutsko-biokemijski fakultet i Zdravstveno veleučilište.

During the past decade, Clinical Hospital Sisters of Mercy conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Hospital Sisters of Mercy" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "SetPoint Medical Corporation" with 2 trials sponsored, "Fresenius Kabi" with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Hospital Sisters of Mercy" #1 collaborator was "B. Braun Melsungen AG" with 1 trials as a collaborator, "European Society of Anaesthesiology and Intensive Care" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Hospital Sisters of Mercy" are "Rheumatoid Arthritis" (3 trials), "Stroke" (2 trials), "Atrial Fibrillation" (1 trials), "Basal Cell Carcinoma" (1 trials) and "Gastric Cancer" (1 trials). Many other conditions were trialed in "Clinical Hospital Sisters of Mercy" in a lesser frequency.

Most popular intervention types in "Clinical Hospital Sisters of Mercy" are "Drug" (6 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyberonics VNS System" (2 trials), "Pertuzumab" (2 trials), "Placebo" (2 trials), "Trastuzumab" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Hospital Sisters of Mercy" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Hospital Sisters of Mercy". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Clinical Hospital Sisters of Mercy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Hospital Sisters of Mercy, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".